Attached files

file filename
EX-23.1 - EX-23.1 - CYTOKINETICS INCf58189exv23w1.htm
EX-31.2 - EX-31.2 - CYTOKINETICS INCf58189exv31w2.htm
EX-31.1 - EX-31.1 - CYTOKINETICS INCf58189exv31w1.htm
EX-10.66 - EX-10.66 - CYTOKINETICS INCf58189exv10w66.htm
EX-10.65 - EX-10.65 - CYTOKINETICS INCf58189exv10w65.htm
10-K - FORM 10-K - CYTOKINETICS INCf58189e10vk.htm
Exhibit 32.1
CEO and CFO CERTIFICATIONS PURSUANT TO
RULE 13a-14(b) AND SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. Section 1350)
Pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Robert I. Blum, President, Chief Executive Officer and Director, and Sharon A. Barbari, Chief Financial Officer, of Cytokinetics, Incorporated (the “Company”), hereby certify that to the best of our knowledge:
1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and to which this certification is attached as Exhibit 32.1 (the “Annual Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
2. The information contained in this Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
  By:   /s/ Robert I. Blum    
    Robert I. Blum,   
    President, Chief Executive Officer and Director
(Principal Executive Officer) 
 
 
     
  By:   /s/ Sharon A. Barbari    
    Sharon A. Barbari,   
    Executive Vice President, Finance and Chief
Financial Officer (Principal Financial Officer) 
 
 
Date: March 10, 2011